Cargando…
COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects
The newly identified severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) causes several heterogeneous clinical conditions collectively known as Coronavirus disease-19 (COVID-19). Older patients with significant cardiovascular conditions and chronic obstructive pulmonary disease (COPD) are p...
Autores principales: | Polverino, Francesca, Kheradmand, Farrah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847987/ https://www.ncbi.nlm.nih.gov/pubmed/33537336 http://dx.doi.org/10.3389/fmed.2020.627278 |
Ejemplares similares
-
Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD
por: Ma, Nan, et al.
Publicado: (2021) -
The optimum timing to wean invasive ventilation for patients with AECOPD or COPD with pulmonary infection
por: Song, Yuanlin, et al.
Publicado: (2016) -
CircRNA0001859, a new diagnostic and prognostic biomarkers for COPD and AECOPD
por: Chen, Shuifang, et al.
Publicado: (2020) -
Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines
por: Brennan, Michelle, et al.
Publicado: (2022) -
Policy during coronavirus disease 2019 (COVID-19) pandemic: a protector for acute exacerbation of COPD (AECOPD) patients?
por: Zeng, Yuqin, et al.
Publicado: (2021)